Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
16 Jun 2016 04:40 PM
RNS
Second Price Monitoring Extn
16 Jun 2016 04:35 PM
RNS
Price Monitoring Extension
15 Jun 2016 12:07 PM
RNS
Second Price Monitoring Extn
15 Jun 2016 12:02 PM
RNS
Price Monitoring Extension
07 Jun 2016 01:14 PM
RNS
Oxford BioMedica Annual General Meeting
07 Jun 2016 07:00 AM
RNS
New Non-Exclusive LentiVector Licence with MolMed
06 Jun 2016 03:29 PM
RNS
OXB to Present at Jefferies Healthcare Conference
02 Jun 2016 10:05 AM
RNS
R&D Partnership with Green Cross LabCell
02 Jun 2016 09:30 AM
RNS
Total Voting Rights
24 May 2016 10:08 AM
RNS
Director/PDMR Shareholding
18 May 2016 07:00 AM
RNS
Deferred Bonus Plan and LTIP Option Grants
17 May 2016 07:00 AM
RNS
Oxford BioMedica Appoints Corporate Broker
16 May 2016 09:23 AM
RNS
Director/PDMR Shareholding
16 May 2016 09:16 AM
RNS
Director/PDMR Shareholding
12 May 2016 07:00 AM
RNS
Oxford BioMedica Board Change
06 May 2016 12:21 PM
RNS
Director/PDMR Shareholding
06 May 2016 07:00 AM
RNS
Long-Term Expression of LentiVector
05 May 2016 05:50 PM
RNS
2015 Annual Report and Accounts & AGM Notification
05 May 2016 09:22 AM
RNS
Director/PDMR Shareholding
04 May 2016 08:48 AM
RNS
Director/PDMR Shareholding
03 May 2016 12:57 PM
RNS
Director/PDMR Shareholding
03 May 2016 09:25 AM
RNS
Total Voting Rights
29 Apr 2016 01:35 PM
RNS
Director Shareholding
28 Apr 2016 07:00 AM
RNS
Preliminary Results for the Year Ended 31 Dec 2015
26 Apr 2016 07:00 AM
RNS
Stuart Henderson Appointed as a NED
25 Apr 2016 08:48 AM
RNS
Director/PDMR Shareholding
15 Apr 2016 08:50 AM
RNS
Holding(s) in Company
01 Apr 2016 09:01 AM
RNS
Total Voting Rights
24 Mar 2016 09:27 AM
RNS
Director Dealings
11 Mar 2016 04:28 PM
RNS
Holding(s) in Company
07 Mar 2016 07:00 AM
RNS
Immune Design Collaboration and Licence Expanded
01 Mar 2016 11:04 AM
RNS
Total Voting Rights
01 Mar 2016 09:46 AM
RNS
Holding(s) in Company
01 Mar 2016 09:44 AM
RNS
Holding(s) in Company
01 Mar 2016 09:38 AM
RNS
Notice of Preliminary Results date: 28 April 2016
29 Feb 2016 12:16 PM
RNS
Director/PDMR Shareholding
26 Feb 2016 04:42 PM
RNS
Holding(s) in Company
25 Feb 2016 05:16 PM
RNS
Director/PDMR Shareholding
25 Feb 2016 02:46 PM
RNS
Holding(s) in Company
25 Feb 2016 02:45 PM
RNS
Director/PDMR Shareholding
25 Feb 2016 09:36 AM
RNS
Holding(s) in Company
23 Feb 2016 07:00 AM
RNS
Placing to raise £8.1 Million
16 Feb 2016 10:59 AM
RNS
Holding(s) in Company
11 Feb 2016 04:40 PM
RNS
Second Price Monitoring Extn
11 Feb 2016 04:35 PM
RNS
Price Monitoring Extension
02 Feb 2016 09:37 AM
RNS
Total Voting Rights
29 Jan 2016 07:00 AM
RNS
Initiation of Second CART Programme for Novartis
13 Jan 2016 07:00 AM
RNS
MHRA approval to manufacture in new facility
05 Jan 2016 07:00 AM
RNS
Directorate Change
04 Jan 2016 07:00 AM
RNS
Blocklisting Interim Review

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings